Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEFFREY A FEINSTEIN

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1609867241
CMS profile
162989
Location
WINDCREST, TX

General Payments · PY2018–2024

$20,724.47

  • Reported across 347 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,172.66

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $1,200.00 1
Food and Beverage $972.66 32

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $1,328.78 3
NOVARTIS PHARMACEUTICALS CORPORATION $332.39 11
Amgen Inc. $151.79 8
Janssen Biotech, Inc. $134.53 1
UCB, Inc. $88.29 3
E.R. Squibb & Sons, L.L.C. $53.94 3
Fresenius Kabi USA, LLC $34.00 1
GlaxoSmithKline, LLC. $28.94 2
Octapharma USA, Inc. $20.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $10,128.32 125
PY2019 $4,602.58 17
PY2020 $287.62 12
PY2021 $544.12 30
PY2022 $1,275.02 72
PY2023 $1,714.15 58
PY2024 $2,172.66 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $1,200.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 1103134225 CMS
ABBVIE INC. $112.31 07/10/2024 Food and Beverage Undisputed 01/23/2026 1103717938 CMS
ABBVIE INC. $16.47 08/29/2024 Food and Beverage Undisputed 01/23/2026 1103717940 CMS
Amgen Inc. $19.33 01/31/2024 Food and Beverage Undisputed 01/23/2026 1111573284 CMS
Amgen Inc. $18.55 03/01/2024 Food and Beverage Undisputed 01/23/2026 1111573286 CMS
Amgen Inc. $17.12 03/28/2024 Food and Beverage Undisputed 01/23/2026 1111573288 CMS
Amgen Inc. $17.40 05/20/2024 Food and Beverage Undisputed 01/23/2026 1111573290 CMS
Amgen Inc. $18.15 07/25/2024 Food and Beverage Undisputed 01/23/2026 1111573292 CMS
Amgen Inc. $17.68 09/25/2024 Food and Beverage Undisputed 01/23/2026 1111573294 CMS
Amgen Inc. $19.39 11/18/2024 Food and Beverage Undisputed 01/23/2026 1111573296 CMS
Amgen Inc. $24.17 12/11/2024 Food and Beverage Undisputed 01/23/2026 1111573298 CMS
E.R. Squibb & Sons, L.L.C. $14.26 05/30/2024 Food and Beverage Undisputed 01/23/2026 1101865791 CMS
E.R. Squibb & Sons, L.L.C. $23.63 07/30/2024 Food and Beverage Undisputed 01/23/2026 1101865813 CMS
E.R. Squibb & Sons, L.L.C. $16.05 09/10/2024 Food and Beverage Undisputed 01/23/2026 1101865942 CMS
Fresenius Kabi USA, LLC $34.00 09/16/2024 Food and Beverage Undisputed 01/23/2026 1146952220 CMS
GlaxoSmithKline, LLC. $14.16 01/24/2024 Food and Beverage Undisputed 01/23/2026 1116661845 CMS
GlaxoSmithKline, LLC. $14.78 03/20/2024 Food and Beverage Undisputed 01/23/2026 1116274125 CMS
Janssen Biotech, Inc. $134.53 11/21/2024 Food and Beverage Undisputed 01/23/2026 1078782076 CMS
Novartis Pharmaceuticals Corporation $28.30 01/29/2024 Food and Beverage Undisputed 01/23/2026 1086837999 CMS
Novartis Pharmaceuticals Corporation $28.14 02/27/2024 Food and Beverage Undisputed 01/23/2026 1086838003 CMS
Novartis Pharmaceuticals Corporation $28.06 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086838001 CMS
Novartis Pharmaceuticals Corporation $30.65 04/25/2024 Food and Beverage Undisputed 01/23/2026 1086838005 CMS
Novartis Pharmaceuticals Corporation $25.67 05/28/2024 Food and Beverage Undisputed 01/23/2026 1086838007 CMS
Novartis Pharmaceuticals Corporation $25.67 06/25/2024 Food and Beverage Undisputed 01/23/2026 1086838009 CMS
Novartis Pharmaceuticals Corporation $28.07 07/24/2024 Food and Beverage Undisputed 01/23/2026 1086838011 CMS
Novartis Pharmaceuticals Corporation $26.84 08/20/2024 Food and Beverage Undisputed 01/23/2026 1086838013 CMS
Novartis Pharmaceuticals Corporation $29.76 09/26/2024 Food and Beverage Undisputed 01/23/2026 1086838033 CMS
Novartis Pharmaceuticals Corporation $22.75 10/23/2024 Food and Beverage Undisputed 01/23/2026 1086838037 CMS
Novartis Pharmaceuticals Corporation $58.48 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086838039 CMS
Octapharma USA, Inc. $20.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 1142314300 CMS
UCB, Inc. $27.46 02/07/2024 Food and Beverage Undisputed 01/23/2026 1143083525 CMS
UCB, Inc. $39.68 04/03/2024 Food and Beverage Undisputed 01/23/2026 1143083527 CMS
UCB, Inc. $21.15 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143083529 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.